Alterations in metabolism are fundamental to the development and progression of renal cell carcinoma (RCC). Through use of a combined proteomic and metabolomic analysis approach, a new paper enhances our understanding of the metabolomic alterations that occur in RCC and highlights new therapeutic targets.
- Denise R. Minton
- David M. Nanus